AVANIR Pharmaceuticals (NASDAQ:AVNR)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Recs

0
Player Avatar 1stMartian (48.80) Submitted: 12/6/2011 1:25:08 PM : Underperform Start Price: $2.50 AVNR Score: -9.07

Declining sales, declining cash flow, horrible ROI.

Featured Broker Partners


Advertisement